- Report
- January 2025
- 152 Pages
Global
From €1965EUR$2,250USD£1,707GBP
- Report
- January 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 193 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- July 2025
- 125 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 188 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 462 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- October 2024
- 200 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- February 2025
- 169 Pages
Latin America
From €7423EUR$8,500USD£6,449GBP
- Report
- October 2024
- 90 Pages
United States
From €5196EUR$5,950USD£4,514GBP
- Report
- June 2025
- 200 Pages
United States
From €2175EUR$2,490USD£1,889GBP
- Report
- April 2025
- 122 Pages
Europe
From €3493EUR$4,000USD£3,035GBP
- Report
- October 2023
- 154 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- January 2024
- 492 Pages
Global
From €4061EUR$4,650USD£3,528GBP
- Report
- June 2022
- 257 Pages
Global
From €2292EUR$2,625USD£1,991GBP
€4585EUR$5,250USD£3,983GBP
- Report
- October 2023
- 120 Pages
India
From €5196EUR$5,950USD£4,514GBP
- Report
- September 2024
- 87 Pages
India
From €3057EUR$3,500USD£2,655GBP
- Report
- May 2024
- 185 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- May 2024
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- November 2023
- 77 Pages
United States
From €3057EUR$3,500USD£2,655GBP

The Oncology NGS market is a subset of the biotechnology industry that focuses on the development of technologies and products related to the diagnosis and treatment of cancer. This includes the use of next-generation sequencing (NGS) to identify genetic mutations in cancer cells, as well as the development of targeted therapies and immunotherapies to treat cancer. NGS is a powerful tool for cancer research, as it can provide a comprehensive view of the genetic makeup of a tumor, allowing for more accurate diagnosis and treatment.
The Oncology NGS market is highly competitive, with a number of companies offering products and services related to cancer diagnosis and treatment. These include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and Qiagen. Additionally, there are a number of smaller companies that specialize in specific areas of oncology NGS, such as bioinformatics, data analysis, and drug development. Show Less Read more